{"slug":"mablink-bioscience","name":"Mablink Bioscience","url":"https://www.gp-intel.com/company/mablink-bioscience","sector":"Biotech","country":"France","hq_city":null,"website":null,"founded_year":null,"ipo_year":null,"status":"exited","current_owner":null,"current_holder":{"name":"Eli Lilly","names":["Eli Lilly"],"since_year":2024,"basis":"trade_sale"},"ownership_periods":5,"ownership":[{"owner":"ANGELOR","fund":"Angelor","fund_vintage":2014,"entry_year":2019,"exit_year":2023,"is_exit":true,"deal_type":"Trade Sale","buyer":"Eli Lilly","moic":null,"sector":"Biotech"},{"owner":"Lazard Elaia Capital","fund":"Elaia Legacy Fund","fund_vintage":2002,"entry_year":2021,"exit_year":2024,"is_exit":true,"deal_type":"Trade Sale","buyer":"Eli Lilly","moic":null,"sector":"Biotech"},{"owner":"Elaia Partners","fund":"Elaia Alpha II","fund_vintage":2020,"entry_year":2021,"exit_year":2023,"is_exit":true,"deal_type":"Trade Sale","buyer":"Eli Lilly","moic":null,"sector":"Biotech"},{"owner":"Merieux Equity Partners","fund":"Mérieux Innovation 1","fund_vintage":2014,"entry_year":2022,"exit_year":2023,"is_exit":true,"deal_type":"Trade Sale","buyer":"Eli Lilly and Company","moic":null,"sector":"Biotech"},{"owner":"Sofinnova Partners","fund":"Sofinnova Capital X","fund_vintage":2021,"entry_year":2022,"exit_year":2023,"is_exit":true,"deal_type":"Trade Sale","buyer":"Eli Lilly","moic":null,"sector":"Biotech"}],"source":"gp-intel.com","license":"CC-BY-4.0","updated_at":"2026-04-21T14:45:54.545Z"}